Toward an understanding of frailty

Annals of Internal Medicine

Volumn 130, Issue 11, 1999, Pages 945-950

  Hamerman, David ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; DISABILITY; FRAILTY; HEALTH CARE COST; HUMAN; NOMENCLATURE; PRIORITY JOURNAL; REVIEW;

EID: 0033008996     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-130-11-199906010-00022     Document Type: Review

References (141)

1. Suzman RM, Manton KG, Willis DP. Introducing the oldest old. In: Suzman RM, Willis DP, Manton KC, eds. The Oldest Old. New York: Oxford Univ Pr; 1992:3-14.
2. Fried LP. Frailty. In: Hazzard WR, Bierman EL, Blass JP, Ettinger WH Jr, Halter JB, eds. Principles of Geriatric Medicine and Gerontology. 3d ed. New York: McGraw-Hill; 1994:1149-55.
3. Powell C. Frailty: help or hindrance? J R Soc Med. 1997;90 Suppl:23-36.
4. van Weel C, Michels J. Dying, not old age, to blame for costs of health care. Lancet. 1997;350:1159-60.
5. Fried LP, Williamson JD, Kaspar J. The epidemiology of frailty: scope of the problem. In: Perry HM 3d, Morley JE, Coe RM, eds. Aging and Musculoskeletal Disorders: Concepts, Diagnosis, and Treatment, New York: Springer; 1993:3-15.
6. Buchner DM, Wagner EH. Preventing frail health. Clin Geriatr Med. 1992; 8:1-17.
7. Brown I, Renwick R, Raphael D. Frailty: constructing a common meaning, definition, and conceptual framework. Int J Rehabil Research. 1995;18:93-102.
8. Speechley M, Tinetti M. Falls and injuries in frail and vigorous community elderly persons. J Am Geriatr Soc. 1991;339:46-52.
9. Strawbridge WJ, Shema SJ, Balfour JL, Hlgby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol. 1998; 53B:S9-16.
10. Winograd CH, Gerety MB, Chung M, Goldstein MK, Dominguez F Jr, Vallone R. Screening for frailty: criteria and predictors of outcomes. J Am Geriatr Soc. 1991;39:778-84.
11. Rockwood K. Medical management of frailty: confessions of a gnostic. CMAJ. 1997;157:1081-4.
12. Hébert R. Functional decline in old age. CMAJ. 1997;157:1037-45.
13. Gealey SG. Quantification of the term frail as applied to the elderly client. J Am Acad Nurse Pract. 1997;9:505-10.
14. Fretwell MD. Acute hospital care for frail older patients. In: Hazzard WR, Bierman EL, Blass JP, Ettinger WH Jr, Halter JB, eds. Principles of Geriatric Medicine and Gerontology. 3d ed. New York: McGraw-Hill; 1994:241-8.
15. Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving concept. CMAJ. 1994;150:489-95.
16. Gill TM, Robison JT, Tinetti ME. Difficulty and dependence: two components of the disability continuum among community-living older persons. Ann Intern Med. 1998;128:96-101.
17. Egbert AM. "The dwindles." Failure to thrive in older patients. Postgrad Med. 1993;94:199-201, 204-6, 210-2.
18. Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci. 1995;50 Spec No:5-8.
19. Roubenoff R, Harris TB. Failure to thrive, sarcopenia and functional decline in the elderly. Clin Geriatr Med. 1997;13:613-22.
20. Hildebrand JK, Joos SK, Lee MA. Use of the diagnosis "failure to thrive" in older veterans. J Am Geriatr Soc. 1997;45:1113-7.
21. Sarkisian CA, Lachs MS. "Failure to thrive" in older adults. Ann Intern Med. 1996;124:1072-8.
22. Verdery RB. Failure to thrive in old age: follow-up on a workshop. J Gerontol A Biol Sci Med Sci. 1997;52:M333-6.
23. Verdery RB. Failure to thrive. In: Hazzard WR, Bierman EL, Blass JP, Ettinger WH Jr, Halter JB, eds. Principles of Geriatric Medicine and Gerontology. 3d ed. New York: McGraw-Hill; 1994:1205-11.
24. Fox KM, Hawkes WG, Magaziner J, Zimmerman SI, Hebel JR. Markers of failure to thrive among older hip fracture patients. J Am Geriatr Soc. 1996;44:371-6.
25. Verdery RB. Failure to thrive in older people. J Am Geriatr Soc. 1996;44:465-6.
26. Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc. 1997;45:92-100.
27. Gonski PN. Acopia - a new DRG? Med J Aust. 1997;167:421-2.
28. Clark LP, Dion DM, Barker WH. Taking to bed. Rapid functional decline in an independently mobile older population living in an intermediate-care facility. J Am Geriatr Soc. 1990;38:967-72.
29. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc. 1995;43:329-37.
30. Roubenoff R. Inflammatory and hormonal mediators of cachexia. J Nutr. 1997;127:1014-6S.
31. Moldawer LL, Copeland EM 3d. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer. 1997;79:1828-39.
32. Gray-Donald K. The frail elderly: meeting the nutritional challenges. J Am Diet Assoc. 1995;95:538-40.
33. Matthys P, Billiau A. Cytokines and cachexia. Nutrition. 1997;13:763-70.
34. Isaacs B, Gunn J, McKechan A, McMillan I, Neville Y. The concept of pre-death. Lancet. 1971;1:1115-8.
35. Jarrett PG, Rockwood K, Carver D, Stollee P, Ccsway S. Illness presentation in elderly patients. Arch Intern Med. 1995;155:1060-4.
36. Resnick NM, Marcantonio ER. How should clinical care of the aged differ? Lancet. 1997;350:1157-8.
37. Ory MG, Schechtman KB, Miller JP, Hadley EC Fiatarone MA, Province MA, et al. Frailty and injuries in later life: the FICSIT trials. J Am Geriatr Soc. 1993;41:283-96.
38. Hadley EC, Ory MG, Suzman R, Weindruch R, Fried L, eds. Physical frailty. A treatable cause of dependence in old age. Proceedings of a symposium. Minneapolis, Minnesota, 18 November 1989. J Gerontol. 1993;48 Spec No:3-88.
39. Brody KK, Johnson RE, Douglas Reid L. Evaluation of a self-report screening instrument to predict frailty outcomes in aging populations. Gerontologist. 1997;37:182-91.
40. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation - allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med. 1997;157:2259-68.
41. Czaja SJ, Weber RA, Nair SN. A human factor analysis of ADL activities: a capability-demand approach. J Gerontol. 1993;48 Spec No:44-8.
42. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-94.
43. Guralnik JM. Assessment of physical performance and disability in older persons. Muscle Nerve Suppl. 1997;5:S14-6.
44. Williamson JD, Fried LP. Targeting disabled and at risk older adults for inclusion in population based studies. Muscle Nerve Suppl. 1997;5:S21-6.
45. Branch LG, Meyers AR. Assessing physical function in the elderly. Clin Geriatr Med. 1987;3:29-51.
46. Reuben DB. Warning signs along the road to functional dependency [Editorial]. Ann Intern Med. 1998;128:138-9.
47. Mulrow CD, Gerety MB, Cornell JE, Lawrence VA, Kanten DN. The relationship between disease and function and perceived health in very frail elders. J Am Geriatr Soc. 1994;42:374-80.
48. Ritchie CS, Burgio KL, Locher JL, Cornwell A, Thomas D, Hardin M, et al. Nutritional states of urban homebound older adults. Am J Clin Nutr. 1997;66:815-8.
49. Harrison JF. The politics of disability: some implications for geriatricians. J R Soc Med. 1997;90 Suppl 32:5-10.
50. Schulz R, Williamson GM. Psychosocial and behavioral dimensions of physical frailty. J Gerontol. 1993;48 Spec No:39-43.
51. Katz IR, DiFilippo S. Neuropsychiatric aspects of failure to thrive in late life. Clin Geriatr Med. 1997;13:623-38.
52. Kim SH, Wolde-Tsadlk G, Reuben DB. Predictors of perceived health in hospitalized older persons: a cross-sectional and longitudinal study. J Am Geriatr Soc. 1997;45:420-6.
53. Frisoni GB, Franzoni S, Rozzini R, Ferrucci L, Boffelli S, Trabucchi M. Food intake and mortality in the frail elderly. J Gerontol A Biol Sci Med Sci. 1995;50A:M203-10.
54. Markson EW. Functional, social, and psychological disability as causes of loss of weight and independence in older community-living people. Clin Geriatr Med 1997;13:639-52.
55. Rosenthal AJ, Sanders KM, McMurtry CT, Jacobs MA, Thompson DD, Gheorghiu D, et al. Is malnutrition overdiagnosed in older hospitalized patients? Association between the soluble interleukin-2 receptor and serum markers of malnutrition. J Gerontol A Biol Sci Med Sci. 1998;53:M81-6.
56. Wagner EH. Preventing decline in function. Evidence from randomized trails around the world. West J Med. 1997;167:295-8.
57. Brown K, Boot D, Groom L, Williams E. Problems found in the over-75s by the annual health check. Br J General Pract. 1997;47:31-5.
58. Williamson J, Stokoe IH, Gray S, Fisher M, Smith A, McGhee A, et al. Old people at home. Their unreported needs. Lancet. 1964;1:1117-20.
59. Rubenstein LZ. Documenting impacts of geriatric consultation [Editorial]. J Am Geriatr Soc. 1987;35:829-30.
60. Rubenstein LZ, Josephson KR, Wieland GD, English PA, Sayre JA, Kane RL. Effectiveness of a geriatric evaluation unit: a randomized clinical trail. N Engl J Med. 1984;311:1664-70.
61. Fries JF. Aging, illness, and health policy: implications of the compression of morbidity. Perspect Biol Med. 1988:31:407-28.
62. Verbrugge LM. Longer life but worsening health? Trends in health and mortality of middle-aged and older persons. Milbank Mem Fund Q Health Soc. 1984;62:475-519.
63. Olshansky SJ, Cassel CK. Implications of the accrual of chronic nonfatal conditions in very elderly persons. In: Hamerman D, ed. Osteoarthritis: Public Health Implications for an Aging Population. Baltimore: Johns Hopkins Univ Pr; 1997:15-29.
64. Boult C, Altmann M, Gilbertson D, Yu C, Kane RL. Decreasing disability in the 21 st century: the future effects of controlling six fatal and nonfatal conditions. Am J Public Health. 1996;86:1388-93.
65. Manton KG, Corder LS, Stallard E. Monitoring changes in the health of the U.S. elderly population: correlates with biomedical research and clinical innovations. FASEB J. 1997;11:923-30.
66. Hochberg MC. Epidemiologic considerations in the primary prevention of Osteoarthritis. J Rheumatol. 1991;18:1438-40.
67. Hamerman D. The aging skeleton - osteoarthritis and osteoporosis. In: Hamerman D, ed. Osteoarthritis: Public Health Implications for an Aging Population. Baltimore: Johns Hopkins Univ Pr; 1997:99-121.
68. Raisz LG. The osteoporosis revolution. Ann Intern Med. 1997;126:458-62.
69. Roses AD. Genetic testing for Alzheimer disease. Practical and ethical issues. Arch Neurol. 1997;54:1226-9.
70. Behl C. Amyloid β-protein toxidty and oxidative stress in Alzheimer's disease. Cell Tissue Res. 1997;290:471-80.
71. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526-34.
72. Tritos NA, Mantzoros CS. Recombinant human growth hormone: old and novel uses. Am J Med. 1998;105:44-57.
73. Bartke A, Brown-Borg HM, Bode AM, Carlson J, Hunter WS, Bronson RT. Does growth hormone prevent or accelerate aging? Exp Gerontol. 1998; 33:675-87.
74. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science. 1997;278:419-24.
75. Lieberman SA, Hoffman AR. The somatopause: should growth hormone deficiency in older people be treated? Clin Geriatr Med. 1997;13:671-84.
76. Toogood AA, O'Neill PA, Shalet SM. Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab. 1996;81:460-5.
77. Bunn PA Jr. Cancer and acquired immunodeficiency syndrome wasting syndromes: current and future therapies. Semin Oncol. 1998;25(2 Suppl 6): 1-3.
78. DeBlaauw I, Deutz NEP, von Meyenfeldt MF. Metabolic changes in cancer cachexia. Clin Nutr. 1997;16:223-8.
79. Rowe JW, Kahn RL .Successful aging. Gerontologist. 1997;37:433-40.
80. Hazzard WR. Ways to make "usual" and "successful" aging synonymous. Preventive gerontology. West J Med. 1997;167:206-15.
81. Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc. 1997;45:482-8.
82. Granville DJ, Carthy CM, Hunt DW, McManus BM. Apoptosis: molecular aspects of cell death and disease. Lab Invest. 1998;78:893-913.
83. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998;78:547-81.
84. Lithgow GJ, Kirkwood TB. Mechanisms and evolution of aging. Science. 1996;273:80.
85. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41:176-81.
86. Mysliwska J, Bryl E, Foerster J, Mysliwski A. Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status. Mech Ageing Develop. 1998;100:313-28.
87. Barton BE. IL-6: insights into novel biological activities. Clin Immunol Immunopathol. 1997;85:16-20.
88. Holden RJ, Pakula IS. The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med Hypotheses. 1996;47:423-38.
89. Dutta C, Hadley EC, Lexell J. Sarcopenia and physical performance in old age: overview. Muscle Nerve Suppl. 1997;5:S5-9.
90. Marcus R. Relationship of age-related decreases in muscle mass and strength to skeletal status. J Gerontol A Biol Sci Med Sci. 1995;50 Spec No:86-7.
91. Cannon JG. Cytokines in aging and muscle homeostasis. J Gerontol A Biol Sci Med Sci. 1995;50 Spec No:120-3.
92. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci. 1997:52 Spec No:M201-8.
93. Dentino AN, Pieper CF, Rao KM, Currie MS, Harris T, Blazer DG, et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc. 1999;47:6-11.
94. Ashcroft GS, Horan MA, Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest. 1998;78:47-58.
95. Manolagas SC. Pathophysiologic role of interleukin-6 in osteoporosis and other bone diseases, pp 132-3. In: Papanicolaou DA, moderator. The pathophysiologic roles of interleukin-6 in human diseases. Ann Intern Med. 1998; 128:127-37.
96. Streckfus CF, Johnson RB, Nick T, Tsao A, Tucci M. Comparison of alveolar bone loss, alveolar bone density and second metacarpal bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy. J Gerontol A Biol Sci Med Sci. 1997;52:M343-51.
97. Richards CD, Gauldie J. Role of cytokines in acute-phase response. In: Aggarwal BA, Puri RK, eds. Human Cytokines: Their Role in Disease and Therapy. Cambridge, MA: Blackwell Science; 1995:253-70.
98. Specter TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997;40:723-7.
99. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121-7.
100. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-11.
101. Ballou SP, Kushner I. Chronic inflammation in older people: recognition, consequences, and potential intervention. Clin Geriatr Med. 1997;13:653-69.
102. Bristow MR. Tumor necrosis factor-γ and cardiomyopathy [Editorial]. Circulation. 1998;97:1340-1.
103. Sridhar MK. Why do patients with emphysema lose weight? Lancet. 1995; 345:1190-1.
104. Bonnefoy M, Coulon L, Blenvenu J, Bolsson RC, Rys L. Implication of cytokines in the aggravation of malnutrition and hypercatabolism in elderly patients with severe pressure sores. Age Ageing. 1995;24:37-42.
105. Sternberg EM. Neural-immune interactions in health and disease. J Clin Invest. 1997;100:2641-7.
106. Seeman TE, Robbins RJ. Aging and the hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev. 1994;15:233-60.
107. Mobbs CV. Neuroendocrinology of aging. In: Schneider EL, Rowe JW, eds. Handbook of the Biology of Aging. 4th ed. San Diego: Academic Pr; 1996; 234-82.
108. Rothwell N, Allan S, Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest. 1997;100:2648-52.
109. Papanicolaou DA. Molecular biology of interleukin-6, pp 127-30. In: Papanicolaou DA, moderator. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127-37.
110. Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest. 1997;100:3105-10.
111. Cefalu WT, Werbel S, Bell-Farrow AD, Terry JG, Wang ZQ, Opara EC, et al. Insulin resistance and fat patterning with aging: relationship to metabolic risk factors for cardiovascular disease. Metabolism. 1998;47:401-8.
112. Morin CL, Pagliassotti MJ, Windmiller D, Eckel RH. Adipose tissue-derived tumor necrosis factor-α activity is elevated in older rats. J Gerontol A Biol Sci Med Sci. 1997;52:B190-5.
113. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest. 1996;97:2152-7.
114. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest. 1997;100: 2777-82.
115. Bessesen DH, Faggioni R. Recently identified peptides involved in the regulation of body weight. Semin Oncol. 1998;25(2 Suppl 6):28-32.
116. Auwerx J, Staels B. Leptin. Lancet. 1998;351:737-42.
117. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes. 1996;45:1455-62.
118. Orban Z, Bornstein SR, Chrousos GP. The interaction between leptin and the hypothalamic-pituitary-thyroid axis. Horm Metab Res. 1998;30:231-5.
119. Li H, Matheny M, Nocolson M, Türner N, Scarpace PJ. Leptin gene expression increases with age independent of increasing adiposity in rats. Diabetes 1997;46:2035-9.
120. Ostlund RE Jr, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab. 1996;81:3909-13.
121. Andersen RE, Blair SN, Cheskin LJ, Bartlett SJ. Encouraging patients to become more physically active: the physician's role. Ann Intern Med. 1997; 127:395-400.
122. Vita AJ, Terry RB, Hubert HB, Fries JF. Aging, health risks, and cumulative disability. N Engl J Med. 1998;338:1035-41.
123. Lee IM, Paffenbarger RS, Jr, Hennekens CH. Physical activity, physical fitness and longevity. Aging Clin Exp Res. 1997;9:2-11.
124. Tseng BS, Marsh DR, Hamilton MT, Booth FW. Strength and aerobic training attenuate muscle wasting and improve resistance to the development of disability with aging. J Gerontol. 1995;50A:113-9.
125. Welndruch R, Sohol RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med. 1998;337:986-94.
126. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991;53(1 Suppl): 189-93S.
127. Cauley JA, Seeley DG, Browner WS, Ensrud K, Kuller LH, Lipschutz RC, et al. Estrogen replacement therapy and mortality among older women. The Study of Osteoporotic Fractures. Arch Intern Med. 1997;157: 2181-7.
128. Morley JE, Kaiser FE, Sih R, Hajjar R, Perry HM 3d. Testosterone and frailty. Clin Geriatr Med. 1997;13:585-95.
129. Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, et al. Effects of recombinant insulin-like growth factor-I and growth hormones on bone turnover in elderly women. J Bone Miner Res. 1995;10:1844-52.
130. Oriander PR, Nader S. Endocrinology. Youthful hormones. Lancet. 1996; 348 Suppl 2:116.
131. Borst SE, Millard WJ, Lowenthal DT. Growth hormone, exercise, and aging: the future of therapy for the frail elderly. J Am Geriatr Soc. 1994;42: 528-35.
132. Shetty KR, Gupta KL, Rudman D. New clinical applications for recombinant human growth hormone. In: Buckwalter JA, Goldberg VM, Woo SL, eds. Musculoskeletal Soft-Tissue Aging: Impact on Mobility. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1993:61-72.
133. Ravaglia G, Forti P. Maioli f. Boschi F, Bernardi M, Prateill L, et al. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab. 1996;81:1173-8.
134. Casson PR, Carson SA, Buster JE. Replacement dehydroepiandrosterone in the elderly: rationale and prospects for the future. Endocrinologist. 1998; 8:187-94.
135. Koopman WJ, Moreland LM. Rheumatoid arthritis: anticytokine therapies on the horizon. Ann Intern Med. 1998;128:231-3.
136. Pugh-Humphreys RG, Thomson AW. Cytokines and their receptors as potential therapeutic targets. In: Thomson AW, ed. The Cytokine Handbook. 2d ed. San Diego: Academic Pr; 1994:525-66.
137. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol. 1998;16:27-55.
138. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273:402-7.
139. Hamerman D. Aging and the musculoskeletal system. Ann Rheum Dis. 1997;56:578-85.
140. Judge JO. The principles and prescription of exercise for frail older persons. In: Hamerman D, ed. Osteoarthritis: Public Health Implications for an Aging Population. Baltimore: Johns Hopkins Univ Pr; 1997:125-49.
141. Rowe JW. The new gerontology [Editorial]. Science. 1997;278:367.